Emiliano Duranti Selected Research

Emiliano Duranti Research Topics

Disease

9	Inflammation (Inflammations) 12/2021 - 10/2006
4	Obesity 10/2018 - 07/2012
4	Essential Hypertension 11/2016 - 03/2009
2	Vascular Remodeling 01/2017 - 01/2016
2	Hypertension (High Blood Pressure) 01/2013 - 01/2011
2	Body Weight (Weight, Body) 11/2010 - 08/2007
2	Colitis 11/2010 - 08/2007
2	Systolic Heart Failure 05/2010 - 03/2010
1	Cognitive Dysfunction 12/2021
1	Alzheimer Disease (Alzheimer's Disease) 12/2021
1	Fibrosis (Cirrhosis) 10/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2015
1	Proteinuria 10/2015
1	Necrosis 04/2015
1	Diarrhea 09/2013
1	Obstructive Sleep Apnea 07/2013
1	Intellectual Disability (Idiocy) 01/2013
1	Abdominal Obesity 01/2013
1	Diabetes Mellitus 01/2013
1	Thrombosis (Thrombus) 01/2013
1	Atherosclerosis 01/2013
1	Rett Syndrome (Rett's Disorder) 01/2013
1	Insulin Resistance 01/2013
1	Dyslipidemias (Dyslipidemia) 01/2013
1	Venous Insufficiency 05/2012
1	Hyperinsulinism (Hyperinsulinemia) 04/2012
1	Vascular System Injuries 01/2011
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2010
1	Left Ventricular Dysfunction 03/2010
1	Weight Gain 08/2007
1	Neoplasms (Cancer) 10/2006
1	Thyroid Neoplasms (Thyroid Cancer) 10/2006
1	Ischemia 10/2006
1	Shock 03/2005

Drug/Important Bio-Agent (IBA)

6	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 10/2006
3	Superoxides (Superoxide)IBA 10/2018 - 02/2009
3	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2018 - 03/2009
3	AntioxidantsIBA 01/2018 - 10/2006
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2013 - 03/2005
2	Nitric Oxide Synthase (NO Synthase)IBA 07/2013 - 07/2011
2	AdipokinesIBA 01/2013 - 08/2012
2	CytokinesIBA 01/2013 - 08/2007
2	2,4-dinitrobenzenesulfonic acidIBA 11/2010 - 08/2007
2	9-(2-hydroxy-3-nonyl)adenine (EHNA)IBA 11/2010 - 08/2007
2	pyrimidineIBA 11/2010 - 08/2007
2	pyrazoleIBA 11/2010 - 08/2007
2	Adenosine (Adenocard)FDA LinkGeneric 11/2010 - 08/2007
2	Adenosine DeaminaseIBA 11/2010 - 08/2007
2	Interleukin-6 (Interleukin 6)IBA 11/2010 - 10/2006
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2010 - 08/2007
1	Donepezil (Aricept)FDA LinkGeneric 12/2021
1	Biological ProductsIBA 08/2019
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 10/2018
1	ArginaseIBA 10/2018
1	FlavonoidsIBA 01/2018
1	LuteolinIBA 01/2018
1	ApigeninIBA 01/2018
1	Cholecalciferol (Vitamin D3)FDA Link 11/2016
1	Metformin (Glucophage)FDA LinkGeneric 01/2016
1	saxagliptin FDA Link 01/2016
1	anti-dsDNA autoantibodyIBA 10/2015
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2015
1	Endothelin-1 (Endothelin 1)IBA 04/2015
1	Endothelins (Endothelin)IBA 04/2015
1	Pharmaceutical PreparationsIBA 03/2014
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2013
1	Serotonin (5 Hydroxytryptamine)IBA 09/2013
1	Hydrocortisone (Cortisol)FDA LinkGeneric 09/2013
1	Neuropeptide YIBA 09/2013
1	Carrier Proteins (Binding Protein)IBA 01/2013
1	CurcuminIBA 01/2013
1	HaptoglobinsIBA 07/2012
1	Insulin (Novolin)FDA Link 04/2012
1	tempolIBA 07/2011
1	Arginine (L-Arginine)FDA Link 07/2011
1	Infliximab (Remicade)FDA Link 07/2011
1	Angiotensin IIIBA 01/2011
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 11/2010
1	Purinergic P1 Receptor AntagonistsIBA 11/2010
1	Adenosine Deaminase InhibitorsIBA 11/2010
1	Biomarkers (Surrogate Marker)IBA 05/2010
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2010
1	Natriuretic PeptidesIBA 05/2010
1	Metalloproteases (Metalloproteinases)IBA 05/2010
1	Matrix Metalloproteinases (MMPs)IBA 03/2010
1	Sulfaphenazole FDA Link 03/2009
1	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 03/2009
1	BradykininIBA 03/2009
1	2,4-dinitrofluorobenzene sulfonic acidIBA 08/2007
1	Thyrotropin Alfa FDA LinkGeneric 10/2006
1	C-Reactive ProteinIBA 10/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2006
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 10/2006
1	Lipid PeroxidesIBA 10/2006
1	Thyroglobulin FDA Link 10/2006
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2005

Therapy/Procedure

2	Therapeutics 11/2016 - 03/2014
1	Sclerotherapy 05/2012